US Stock MarketDetailed Quotes
OCUL Ocular Therapeutix
- 6.170
- +0.300+5.11%
Close May 3 16:00 ET
- 6.370
- +0.200+3.24%
Post 16:24 ET
954.66MMarket Cap-6049P/E (TTM)
6.395High6.030Low4.64MVolume6.060Open5.870Pre Close28.86MTurnover3.45%Turnover RatioLossP/E (Static)154.73MShares11.31052wk High10.48P/B830.04MFloat Cap1.99552wk Low--Dividend TTM134.53MShs Float44.190Historical High--Div YieldTTM6.22%Amplitude1.995Historical Low6.218Avg Price1Lot Size
Ocular Therapeutix Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -17.84%-70.23M | -32.41%-22.45M | 41.29%-7.73M | -84.58%-20.08M | -7.38%-19.97M | 9.07%-59.6M | -11.91%-16.96M | -1.44%-13.17M | 45.77%-10.88M | -7.15%-18.6M |
| Net income from continuing operations | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M | -984.05%-71.04M | -303.69%-15.54M | -1,010.35%-24.19M | -121.27%-18.77M | -501.86%-12.54M |
| Operating gains losses | 34.96%-9M | 223.59%6.48M | -1,947.35%-20.91M | 59.21%-1.13M | 194.34%6.56M | 82.28%-13.84M | 66.97%-5.24M | 104.75%1.13M | 79.30%-2.77M | 72.19%-6.96M |
| Depreciation and amortization | 41.44%2.98M | 95.11%958K | 74.85%890K | 18.12%652K | -13.29%483K | -12.89%2.11M | -13.86%491K | -14.31%509K | -9.66%552K | -13.78%557K |
| Other non cash items | 25.82%6.11M | 25.55%1.55M | 69.14%2.07M | 3.98%1.25M | 3.54%1.23M | 4.86%4.85M | 4.12%1.24M | 5.79%1.23M | 4.78%1.21M | 4.77%1.19M |
| Change In working capital | -649.37%-7.41M | -206.93%-6.55M | 59.01%6.22M | -199.03%-4.58M | 50.53%-2.5M | 146.50%1.35M | -107.28%-2.14M | 45.52%3.91M | 209.29%4.63M | -1,440.85%-5.05M |
| -Change in receivables | -2,454.74%-4.85M | -70.06%-2.59M | 447.06%3.72M | -326.97%-6.19M | 109.70%201K | 97.86%-190K | 3.79%-1.52M | 183.13%680K | 153.40%2.73M | -50.25%-2.07M |
| -Change in inventory | 54.28%-331K | 88.81%-48K | -17.78%-53K | 143.66%62K | -170.37%-292K | -1,377.55%-724K | -1,432.14%-429K | 59.09%-45K | -1,390.91%-142K | -238.46%-108K |
| -Change in prepaid assets | -620.89%-3.77M | -312.96%-2.93M | -155.69%-269K | -82.39%153K | -986.42%-718K | 815.84%723K | 18.76%-710K | -48.62%483K | 206.36%869K | -87.54%81K |
| -Change in payables and accrued expense | 32.55%1.36M | -172.39%-590K | -4.02%2.84M | -49.86%705K | 61.48%-1.6M | -81.44%1.02M | 47.11%815K | 6.74%2.96M | -20.61%1.41M | -1,109.95%-4.16M |
| -Change in other current assets | 149.45%1.57M | ---- | ---- | ---- | 168.57%72K | -424.97%-3.18M | ---- | ---- | ---- | -146.26%-105K |
| -Change in other current liabilities | -166.43%-1.81M | ---- | ---- | ---- | ---- | 300.96%2.73M | ---- | ---- | ---- | ---- |
| -Change in other working capital | -55.66%427K | -194.94%-150K | 88.10%-20K | 323.96%757K | -112.20%-160K | -3.70%963K | --158K | ---168K | ---338K | --1.31M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -17.84%-70.23M | -32.41%-22.45M | 41.29%-7.73M | -84.58%-20.08M | -7.38%-19.97M | 9.07%-59.6M | -11.91%-16.96M | -1.44%-13.17M | 45.77%-10.88M | -7.15%-18.6M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -63.85%-6.09M | 78.65%-459K | 67.38%-259K | -302.02%-1.99M | -1,124.28%-3.38M | -211.14%-3.72M | -240.73%-2.15M | -187.68%-794K | -283.72%-495K | -74.68%-276K |
| Net PPE purchase and sale | -63.85%-6.09M | 78.65%-459K | 67.38%-259K | -302.02%-1.99M | -1,124.28%-3.38M | -211.14%-3.72M | -240.73%-2.15M | -187.68%-794K | -283.72%-495K | -74.68%-276K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -63.85%-6.09M | 78.65%-459K | 67.38%-259K | -302.02%-1.99M | -1,124.28%-3.38M | -211.14%-3.72M | -240.73%-2.15M | -187.68%-794K | -283.72%-495K | -74.68%-276K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 11,580.06%169.83M | 23,517.90%108.17M | 13,786.36%51.94M | 1,856.39%9.65M | -39.53%78K | -49.00%1.45M | -31.33%458K | -44.92%374K | -81.51%493K | 111.11%129K |
| Net issuance payments of debt | --56.35M | --0 | --56.35M | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net common stock issuance | --117.26M | --107.73M | --708K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | -3.58%1.4M | -3.71%441K | -83.42%62K | 66.53%821K | -39.53%78K | -59.28%1.45M | -31.33%458K | -44.92%374K | -52.04%493K | -89.22%129K |
| Net other financing activities | ---5.18M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 11,580.06%169.83M | 23,517.90%108.17M | 13,786.36%51.94M | 1,856.39%9.65M | -39.53%78K | -49.00%1.45M | -31.33%458K | -44.92%374K | -81.51%493K | 111.10%129K |
| Net cash flow | ||||||||||
| Beginning cash position | -37.28%104.06M | -8.47%112.31M | -49.84%68.37M | -45.11%80.79M | -37.28%104.06M | -27.80%165.93M | -32.22%122.71M | -29.60%136.3M | -30.29%147.18M | -27.80%165.93M |
| Current changes in cash | 251.15%93.51M | 557.14%85.26M | 423.38%43.94M | -14.18%-12.42M | -24.15%-23.27M | 3.18%-61.86M | -23.37%-18.65M | -8.03%-13.59M | 37.90%-10.88M | -0.36%-18.75M |
| End cash Position | 89.86%197.57M | 89.86%197.57M | -8.47%112.31M | -49.84%68.37M | -45.11%80.79M | -37.28%104.06M | -37.28%104.06M | -32.22%122.71M | -29.60%136.3M | -30.29%147.18M |
| Free cash flow | -20.54%-76.32M | -19.91%-22.91M | 42.77%-7.99M | -94.05%-22.07M | -23.71%-23.35M | 5.13%-63.32M | -21.06%-19.11M | -5.32%-13.96M | 43.67%-11.37M | -7.76%-18.88M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
